GlaxoSmithKline (GB:GSK) has released an update.
GlaxoSmithKline PLC has announced that as of September 30, 2024, its issued share capital comprises 4,314,258,970 Ordinary Shares, with 169,171,155 shares held in Treasury, resulting in a total of 4,145,087,815 voting rights available to shareholders. Shareholders may use this total figure as the denominator to calculate notification requirements for changes in shareholding interests as per the Financial Conduct Authority’s rules.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.